Suchergebnisse - "Su, Yongwei"

PubPharm (35)

1

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

enthalten in: Cancer research | 2024

von Su, Y. | Carter, J. | Li, X. | +31

2

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

enthalten in: Biochemical pharmacology | 2024

von Hurrish, K. | Su, Y. | Patel, S. | +26

UpdateOf: Res Sq. 2023 Apr 28;:. - PMID 37162954

3

Application of Remodelin and Venetoclax in cancer treatment

enthalten in: Europäisches Patentamt | 2023

von ZHOU JINGFENG | LI SHUYI | SU YONGWEI | +3

4

Pharmaceutical composition for treating acute myelogenous leukemia

enthalten in: Europäisches Patentamt | 2023

von ZHOU JINGFENG | SU YONGWEI | LI SHUYI | +3

5

Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia : In vitro models and mechanisms

enthalten in: Biochemical pharmacology | 2023

von Carter, J. | Su, Y. | Qiao, X. | +10

6

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and purine biosynthesis

enthalten in: ResearchSquare.com | 2023

von Baran, N. | Hurrish, K. | Su, Y. | +24

7

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis

enthalten in: Research square | 2023

von Hurrish, K. | Su, Y. | Patel, S. | +24

UpdateIn: Biochem Pharmacol. 2023 Dec 10;220:115981. - PMID 38081370

8

Effect of fruit on glucose control in diabetes mellitus : a meta-analysis of nineteen randomized controlled trials

enthalten in: Frontiers in endocrinology | 2023

von Ren, Y. | Sun, S. | Su, Y. | +2

9

Does pronator quadratus repair affect functional outcome following volar plate fixation of distal radius fractures? A systematic review and meta-analysis

enthalten in: Frontiers in medicine | 2023

von Ying, L. | Cai, G. | Zhu, Z. | +3

10

c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia

enthalten in: Apoptosis : an international journal on programmed cell death | 2022

von Liu, S. | Qiao, X. | Wu, S. | +8